Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 14 de 14
Filter
Add more filters










Publication year range
1.
J Neurochem ; 122(3): 545-56, 2012 Aug.
Article in English | MEDLINE | ID: mdl-22639911

ABSTRACT

Hyperammonemia is a major pathophysiological factor in encephalopathies associated with acute and chronic liver failure. On mouse brain slice preparations, we analyzed the effects of ammonia on the characteristics of corticostriatal long-term depression (LTD) induced by electrical stimulation of cortical input or pharmacological activation of metabotropic glutamate receptors. Long exposure of neostriatal slices to ammonium chloride impaired the induction and/or expression of all studied forms of LTD. This impairment was reversed by the phosphodiesterase inhibitor zaprinast implying lowered cGMP signaling in LTD suppression. Polyphenols from green tea rescued short-term corticostriatal plasticity, but failed to prevent the ammonia-induced deficit of LTD. Zaprinast counteracts the ammonia-induced impairment of long-term corticostriatal plasticity and may thus improve fine motor skills and procedural learning in hepatic encephalopathy.


Subject(s)
Ammonia/pharmacology , Cerebral Cortex/cytology , Corpus Striatum/cytology , Long-Term Synaptic Depression/drug effects , Phosphodiesterase Inhibitors/pharmacology , Purinones/pharmacology , Synapses/drug effects , Animals , Antioxidants/pharmacology , Biophysics , Cerebral Cortex/drug effects , Cerebral Cortex/physiology , Corpus Striatum/drug effects , Corpus Striatum/physiology , Cycloheximide/pharmacology , Drug Interactions , Electric Stimulation , In Vitro Techniques , Male , Methoxyhydroxyphenylglycol/analogs & derivatives , Methoxyhydroxyphenylglycol/pharmacology , Mice , Mice, Inbred C57BL , Polyphenols/pharmacology , Protein Synthesis Inhibitors/pharmacology
2.
Hippocampus ; 20(3): 377-88, 2010 Mar.
Article in English | MEDLINE | ID: mdl-19437502

ABSTRACT

Hippocampal plasticity and mnemonic processing exhibit a striking time-of-day dependence and likely implicate a temporally structured replay of memory traces. Molecular mechanisms fulfilling the requirements of sensing time and capturing time-related information are coded in dynamics of so-called clock genes and their protein products, first discovered and described in the hypothalamic suprachiasmatic nucleus. Using real-time PCR and immunohistochemical analyses, we show that in wildtype mice core clock components (mPer1/PER1, mPer2/PER2, mCry1/CRY1, mCry2/CRY2, mClock/CLOCK, mBmal1/BMAL1) are expressed in neurons of all subregions of the hippocampus in a time-locked fashion over a 24-h (diurnal) day/night cycle. Temporal profiling of these transcriptional regulators reveals distinct and parallel peaks, at times when memory traces are usually formed and/or consolidated. The coordinated rhythmic expression of hippocampal clock gene expression is greatly disordered in mice deficient for the clock gene mPer1, a key player implicated in both, maintenance and adaptative plasticity of circadian clocks. Moreover, Per1-knockout animals are severely handicapped in a hippocampus-dependent long-term spatial learning paradigm. We propose that the dynamics of hippocampal clock gene expression imprint a temporal structure on memory processing and shape at the same time the efficacy of behavioral learning.


Subject(s)
Circadian Rhythm Signaling Peptides and Proteins/genetics , Hippocampus/metabolism , Memory/physiology , Period Circadian Proteins/genetics , Time Perception/physiology , ARNTL Transcription Factors/genetics , ARNTL Transcription Factors/metabolism , Animals , Biological Clocks/genetics , CLOCK Proteins/genetics , CLOCK Proteins/metabolism , Circadian Rhythm/genetics , Circadian Rhythm Signaling Peptides and Proteins/metabolism , Cryptochromes/genetics , Cryptochromes/metabolism , Gene Expression Regulation/physiology , Hippocampus/physiopathology , Immunohistochemistry , Male , Memory Disorders/genetics , Mice , Mice, Inbred C3H , Mice, Knockout , Period Circadian Proteins/metabolism , RNA, Messenger/metabolism , Reverse Transcriptase Polymerase Chain Reaction , Time Factors , Transcription Factors/genetics , Transcription Factors/metabolism
3.
J Neurosci ; 29(14): 4471-83, 2009 Apr 08.
Article in English | MEDLINE | ID: mdl-19357273

ABSTRACT

The histaminergic tuberomamillary nucleus (TMN) controls arousal and attention, and the firing of TMN neurons is state-dependent, active during waking, silent during sleep. Thyrotropin-releasing hormone (TRH) promotes arousal and combats sleepiness associated with narcolepsy. Single-cell reverse-transcription-PCR demonstrated variable expression of the two known TRH receptors in the majority of TMN neurons. TRH increased the firing rate of most (ca 70%) TMN neurons. This excitation was abolished by the TRH receptor antagonist chlordiazepoxide (CDZ; 50 mum). In the presence of tetrodotoxin (TTX), TRH depolarized TMN neurons without obvious change of their input resistance. This effect reversed at the potential typical for nonselective cation channels. The potassium channel blockers barium and cesium did not influence the TRH-induced depolarization. TRH effects were antagonized by inhibitors of the Na(+)/Ca(2+) exchanger, KB-R7943 and benzamil. The frequency of GABAergic spontaneous IPSCs was either increased (TTX-insensitive) or decreased [TTX-sensitive spontaneous IPSCs (sIPSCs)] by TRH, indicating a heterogeneous modulation of GABAergic inputs by TRH. Facilitation but not depression of sIPSC frequency by TRH was missing in the presence of the kappa-opioid receptor antagonist nor-binaltorphimine. Montirelin (TRH analog, 1 mg/kg, i.p.) induced waking in wild-type mice but not in histidine decarboxylase knock-out mice lacking histamine. Inhibition of histamine synthesis by (S)-alpha-fluoromethylhistidine blocked the arousal effect of montirelin in wild-type mice. We conclude that direct receptor-mediated excitation of rodent TMN neurons by TRH demands activation of nonselective cation channels as well as electrogenic Na(+)/Ca(2+) exchange. Our findings indicate a key role of the brain histamine system in TRH-induced arousal.


Subject(s)
Histamine/physiology , Hypothalamic Area, Lateral/physiology , Neurons/physiology , Thyrotropin-Releasing Hormone/physiology , Action Potentials/physiology , Animals , Calcium Channels/metabolism , Calcium Channels/physiology , Cations, Divalent/metabolism , Histamine/deficiency , Hypothalamic Area, Lateral/metabolism , Inhibitory Postsynaptic Potentials/physiology , Male , Mice , Mice, Knockout , Neurons/metabolism , Rats , Rats, Wistar , Receptors, Thyrotropin-Releasing Hormone/agonists , Receptors, Thyrotropin-Releasing Hormone/antagonists & inhibitors , Receptors, Thyrotropin-Releasing Hormone/physiology , Sleep Stages/physiology , Sodium Channels/metabolism , Sodium Channels/physiology
4.
Physiol Rev ; 88(3): 1183-241, 2008 Jul.
Article in English | MEDLINE | ID: mdl-18626069

ABSTRACT

Histamine is a transmitter in the nervous system and a signaling molecule in the gut, the skin, and the immune system. Histaminergic neurons in mammalian brain are located exclusively in the tuberomamillary nucleus of the posterior hypothalamus and send their axons all over the central nervous system. Active solely during waking, they maintain wakefulness and attention. Three of the four known histamine receptors and binding to glutamate NMDA receptors serve multiple functions in the brain, particularly control of excitability and plasticity. H1 and H2 receptor-mediated actions are mostly excitatory; H3 receptors act as inhibitory auto- and heteroreceptors. Mutual interactions with other transmitter systems form a network that links basic homeostatic and higher brain functions, including sleep-wake regulation, circadian and feeding rhythms, immunity, learning, and memory in health and disease.


Subject(s)
Histamine/metabolism , Nervous System/metabolism , Signal Transduction , Animals , Brain/metabolism , Homeostasis , Humans , Hypothalamic Area, Lateral/metabolism , Nervous System Diseases/metabolism , Receptors, Histamine/metabolism
5.
Hepatology ; 48(2): 567-79, 2008 Aug.
Article in English | MEDLINE | ID: mdl-18506841

ABSTRACT

UNLABELLED: Oxidative stress plays a major role in cerebral ammonia toxicity and the pathogenesis of hepatic encephalopathy (HE). As shown in this study, ammonia induces a rapid RNA oxidation in cultured rat astrocytes, vital mouse brain slices, and rat brain in vivo. Ammonia-induced RNA oxidation in cultured astrocytes is reversible and sensitive to MK-801, 1,2-Bis(o-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid, apocynin, epigallocatechin gallate, and polyphenon 60, suggesting the involvement of N-methyl-D-aspartic acid (NMDA) receptor activation, Ca(2+), nicotinamide adenine dinucleotide phosphate, and reduced form (NADPH) oxidase-dependent oxidative stress. Also, hypo-osmolarity, tumor necrosis factor alpha (TNF-alpha), and diazepam increase RNA oxidation in cultured astrocytes, suggesting that the action of different HE-precipitating factors converges at the level of RNA oxidation. Among the oxidized RNA species, 18S-rRNA and the messenger RNA (mRNA) coding for the glutamate/aspartate transporter (GLAST) were identified. Cerebral RNA oxidation in acutely ammonia-loaded rats in vivo is reversible and predominates in neuronal soma and perivascular astrocyte processes. In neuronal dendrites, oxidized RNA colocalizes with the RNA-binding splicing protein neurooncological ventral antigen (NOVA)-2 within putative RNA transport granules, which are also found in close vicinity to postsynaptic spines. This indicates that oxidized RNA species may participate in postsynaptic protein synthesis, which is a biochemical substrate for learning and memory consolidation. Neuronal and astroglial RNA oxidation increases also in vital mouse brain slices treated with ammonia and TNF-alpha, respectively. CONCLUSION: Cerebral RNA oxidation is identified as a not yet recognized consequence of acute ammonia intoxication. RNA oxidation may affect gene expression and local protein synthesis and thereby provide another link between reactive oxygen species (ROS)/reactive nitrogen oxide species (RNOS) production and ammonia toxicity.


Subject(s)
Ammonia/pharmacology , Astrocytes/metabolism , Brain/metabolism , RNA/metabolism , Amino Acid Transport System X-AG/genetics , Animals , Astrocytes/drug effects , Brain/cytology , Cells, Cultured , Dendrites/metabolism , Diazepam/pharmacology , In Vitro Techniques , Male , Mice , Mice, Inbred C57BL , Neurons/metabolism , Osmolar Concentration , Oxidation-Reduction/drug effects , RNA Transport , RNA, Messenger/metabolism , RNA, Ribosomal, 18S/metabolism , Rats , Rats, Wistar , Tissue Distribution , Tumor Necrosis Factor-alpha/pharmacology
6.
Glia ; 55(7): 758-71, 2007 May.
Article in English | MEDLINE | ID: mdl-17352382

ABSTRACT

The role of NADPH oxidase (NOX) and the regulatory subunit p47(phox) for hypoosmotic ROS generation was studied in cultured rat astrocytes and brain slices of wilde type and p47(phox) knock-out mice. Cultured rat astrocytes express mRNAs encoding for the regulatory subunit p47(phox), NOX1, 2, and 4, and the dual oxidases (DUOX)1 and 2, but not NOX3. Hypoosmotic (205 mosmol/L) swelling of cultured astrocytes induced a rapid generation of ROS that was accompanied by serine phosphorylation of p47(phox) and prevented by the NADPH oxidase inhibitor apocynin. Apocynin also impaired the hypoosmotic tyrosine phosphorylation of Src. Both, hypoosmotic ROS generation and p47(phox) serine phosphorylation were sensitive to the acidic sphingomyelinase inhibitors AY9944 and desipramine, the protein kinase C (PKC)zeta-inhibitory pseudosubstrate peptide, the NMDA receptor antagonist MK-801 and the intracellular Ca(2+) chelator BAPTA-AM. Also hypoosmotic exposure of wilde type mouse cortical brain slices increased ROS generation, which was allocated in part to the astrocytes and which was absent in presence of apocynin and in cortical brain slices from p47(phox) knock-out mice. Also ammonia induced a rapid ROS production in cultured astrocytes and brain slices, which was sensitive to apocynin. The data suggest that astrocyte swelling triggers a p47(phox)-dependent NADPH oxidase-catalyzed ROS production. The findings further support a close interrelation between osmotic and oxidative stress in astrocytes, which may be relevant to different brain pathologies including hepatic encephalopathy.


Subject(s)
Brain Edema/metabolism , Hepatic Encephalopathy/metabolism , Hyperammonemia/metabolism , NADPH Oxidases/metabolism , Oxidative Stress , Ammonia/metabolism , Ammonia/toxicity , Animals , Animals, Newborn , Astrocytes/drug effects , Astrocytes/metabolism , Brain/drug effects , Brain/metabolism , Brain/physiopathology , Brain Edema/physiopathology , Cells, Cultured , Enzyme Inhibitors/pharmacology , Hepatic Encephalopathy/physiopathology , Hyperammonemia/physiopathology , Male , Mice , Mice, Inbred C57BL , Mice, Knockout , NADPH Oxidases/genetics , Organ Culture Techniques , Osmotic Pressure , Rats , Rats, Wistar , Reactive Oxygen Species/metabolism , Water-Electrolyte Balance/drug effects , Water-Electrolyte Balance/physiology
7.
Hepatology ; 45(3): 695-704, 2007 Mar.
Article in English | MEDLINE | ID: mdl-17326144

ABSTRACT

UNLABELLED: Sinusoidal endothelial cells (SEC) constitute a permeable barrier between hepatocytes and blood. SEC are exposed to high concentrations of bile salts from the enterohepatic circulation. Whether SEC are responsive to bile salts is unknown. TGR5, a G-protein-coupled bile acid receptor, which triggers cAMP formation, has been discovered recently in macrophages. In this study, rat TGR5 was cloned and antibodies directed against the C-terminus of rat TGR5 were developed, which detected TGR5 as a glycoprotein in transfected HepG2-cells. Apart from Kupffer cells, TGR5 was detected in SEC of rat liver. SEC expressed TGR5 over the entire acinus, whereas endothelial cells of the portal or central veins were not immunoreactive toward TGR5 antibodies. In isolated SEC, TGR5 mRNA and protein were detected by reverse transcription (RT) PCR, immunofluorescence microscopy, and Western blot analysis. Bile salts increased cAMP in isolated SEC and induced mRNA expression of endothelial NO synthase (eNOS), a known cAMP-dependent gene. In addition, bile acids activated eNOS by phosphorylation of eNOS at amino acid position 1177. In line with eNOS activation, bile acids induced NO production in liver slices. This is the first report on the expression of TGR5 in SEC. CONCLUSION: The data suggest that SEC are directly responsive toward specific bile salts. Regulation of eNOS in SEC by TGR5 connects bile salts with hepatic hemodynamics. This is of particular importance in cholestatic livers when bile salt concentrations are increased.


Subject(s)
Liver/metabolism , Receptors, G-Protein-Coupled/metabolism , Animals , Bile Acids and Salts/metabolism , Cell Line , Cell Line, Tumor , Cyclic AMP/genetics , Cyclic AMP/metabolism , Endothelial Cells/metabolism , Humans , Kupffer Cells/metabolism , Liver/cytology , Macrophages/metabolism , Male , Nitric Oxide Synthase/genetics , Nitric Oxide Synthase/metabolism , RNA, Messenger/metabolism , Rats , Rats, Wistar , Receptors, G-Protein-Coupled/genetics
8.
Chronobiol Int ; 23(1-2): 63-70, 2006.
Article in English | MEDLINE | ID: mdl-16687280

ABSTRACT

The appropriate time and place for sleep and waking are important factors for survival. Sleep and waking, rest and activity, flight and fight, feeding, and reproduction are all organized in relation to the day and night. A biological clock, the suprachiasmatic nucleus (SCN), synchronized by photic influences and other environmental cues, provides an endogenous timing signal that entrains circadian body rhythms and is complemented by a homeostatic sleep pressure factor. Cholinergic, catecholaminergic, serotonergic, and histaminergic nuclei control wakefulness and mutually interact with the SCN as well as sleep- and wake-promoting neurons in the hypothalamus to form a bistable switch that controls the timing of behavioral state transitions. Hypocretin neurons integrate circadian-photic and nutritional-metabolic influences and act as a conductor in the aminergic orchestra. Their loss causes narcolepsy, a disease conferring the inability to separate sleep and waking. Their role in appetitive behavior, stress, and memory functions is important to our understanding of addiction and compulsion.


Subject(s)
Intracellular Signaling Peptides and Proteins/physiology , Neuropeptides/physiology , Behavior , Biological Clocks , Humans , Hypothalamus/metabolism , Intracellular Signaling Peptides and Proteins/metabolism , Models, Anatomic , Models, Biological , Narcolepsy/physiopathology , Neurons/metabolism , Neuropeptides/metabolism , Orexins , Sleep , Wakefulness
9.
Proc Natl Acad Sci U S A ; 103(1): 195-200, 2006 Jan 03.
Article in English | MEDLINE | ID: mdl-16368758

ABSTRACT

Corticosteroid action in the brain is mediated by the mineralocorticoid (MR) and the glucocorticoid (GR) receptor. Disturbances in MR- and GR-mediated effects are thought to impair cognition, behavior, and endocrine control. To assess the function of the limbic MR in these processes, we inactivated the MR gene in the forebrain of the mouse using the Cre/loxP-recombination system. We screened the mice with a limbic MR deficiency in various learning and exploration tests. The mutant mice show impaired learning of the water-maze task and deficits in measures of working memory on the radial maze due to behavioral perseverance and stereotypy. They exhibit a hyperreactivity toward a novel object but normal anxiety-like behavior. The behavioral changes are associated with abnormalities of the mossy fiber projection and an up-regulation of GR expression in the hippocampus. Adult mutant mice show normal corticosterone levels at circadian trough and peak. This genetic model provides important information about the consequences of a permanently altered balance between limbic MR and GR, with implications for stress-related neuroendocrine and neuropsychiatric diseases.


Subject(s)
Hippocampus/metabolism , Maze Learning/physiology , Memory/physiology , Receptors, Mineralocorticoid/deficiency , Animals , Corticosterone/blood , Female , Immunohistochemistry , Male , Mice , Mice, Transgenic , Models, Genetic , Receptors, Glucocorticoid/metabolism , Receptors, Mineralocorticoid/genetics , Stereotyped Behavior/physiology
10.
Neuropharmacology ; 46(7): 1018-22, 2004 Jun.
Article in English | MEDLINE | ID: mdl-15081798

ABSTRACT

Nuclei of the brainstem involved in behavioral state control are mutually interconnected. Histaminergic neurons of the posterior hypothalamus receive inputs from brainstem noradrenergic cell groups as well as from the locus coeruleus. The role of adrenergic inputs in histaminergic function is unclear. We examined the actions of adrenergic agonists on histaminergic neurons of the tuberomamillary nucleus (TM) using electrophysiological methods in a brain slice preparation. Evoked GABAergic inhibitory postsynaptic potentials (IPSPs) in histaminergic neurons were reduced in amplitude following the application of norepinephrine (NE) (2-20 microM) or clonidine (10 microM) but were not affected by isoproterenol (10 microM). Norepinephrine application caused no changes in membrane properties of TM neurons. Responses to exogenously applied GABA were unaffected by adrenergic agonists. Clonidine reduced the frequency of spontaneous IPSPs, an action that was blocked by yohimbine. Norepinephrine did not alter the amplitude distribution of bicuculline-sensitive miniature inhibitory postsynaptic currents (mIPSCs). Thus, GABA release onto TM neurons is modulated presynaptically by adrenergic alpha(2)-receptors. Inputs from noradrenergic neurons of the brainstem will reduce the inhibitory actions of GABAergic inputs resulting in disinhibition of histaminergic neurons.


Subject(s)
Histamine/physiology , Presynaptic Terminals/physiology , Receptors, Adrenergic, alpha-2/physiology , Synaptic Transmission/physiology , gamma-Aminobutyric Acid/physiology , Adrenergic alpha-2 Receptor Agonists , Adrenergic alpha-2 Receptor Antagonists , Animals , Female , Male , Neural Inhibition/drug effects , Neural Inhibition/physiology , Neurons/drug effects , Neurons/physiology , Norepinephrine/pharmacology , Presynaptic Terminals/drug effects , Rats , Rats, Wistar , Synaptic Transmission/drug effects , Yohimbine/pharmacology , gamma-Aminobutyric Acid/pharmacology
11.
Eur J Neurosci ; 19(5): 1278-84, 2004 Mar.
Article in English | MEDLINE | ID: mdl-15016085

ABSTRACT

High activity of the histaminergic neurons in the tuberomammillary (TM) nucleus increases wakefulness, and their firing rate is highest during waking and lowest during rapid eye movement sleep. The TM neurons receive a prominent innervation from sleep-active gamma-aminobutyric acidergic (GABAergic) neurons in the ventrolateral preoptic nucleus, which inhibits them during sleep. They also receive an excitatory input from the orexin- and dynorphin-containing neurons in the lateral hypothalamus, which are critically involved in sleep regulation and whose dysfunction causes narcolepsy. We have used intracellular recordings and immunohistochemistry to study if orexin neurons exert control over the GABAergic inputs to TM neurons in rat hypothalamic slices. Dynorphin suppressed GABAergic inputs and thus disinhibits the TM neurons, acting in concert with orexin to increase the excitability of these neurons. In contrast, both orexin-A and orexin-B markedly increased the frequency of GABAergic potentials, while co-application of orexin and dynorphin produced responses similar to dynorphin alone. Thus, orexins excite TM neurons directly and by disinhibition, gated by dynorphin. These data might explain some of the neuropathology of narcolepsy.


Subject(s)
Carrier Proteins/physiology , Dynorphins/physiology , Hypothalamic Area, Lateral/physiology , Intracellular Signaling Peptides and Proteins , Neurons/physiology , Neuropeptides/physiology , gamma-Aminobutyric Acid/physiology , Animals , Enkephalin, Ala(2)-MePhe(4)-Gly(5)-/pharmacology , Hypothalamic Area, Lateral/drug effects , Male , Neurons/drug effects , Orexins , Rats , Rats, Wistar , Synaptic Transmission/drug effects , Synaptic Transmission/physiology
12.
Blood ; 104(1): 81-8, 2004 Jul 01.
Article in English | MEDLINE | ID: mdl-15016651

ABSTRACT

Recently, overlapping molecular phenotypes of hematopoietic and neuropoietic cells were described in mice. Here, we examined primary human CD34(+) hematopoietic stem and progenitor cells applying specialized cDNA arrays, real-time reverse-transcriptase-polymerase chain reaction (RT-PCR), and fluorescent-activated cell sorter (FACS) analysis focusing on genes involved in neurobiologic functions. We found expression of vesicle fusion and motility genes, ligand- and voltage-gated ion channels, receptor kinases and phosphatases, and, most interestingly, mRNA as well as protein expression of G protein-coupled receptors of neuromediators (corticotropin-releasing hormone 1 [CRH 1] and CRH 2 receptors, orexin/hypocretin 1 and 2 receptors, GABAB receptor, adenosine A(2)B receptor, opioid kappa 1 and mu 1 receptors, and 5-HT 1F receptor). As shown by 2-color immunofluorescence, the protein expression of these receptors was higher in the more immature CD38(dim) than in the CD38(bright) subset within the CD34(+) population, and completely absent in fully differentiated blood cells, suggesting that those receptors play a role in developmentally early CD34(+) stem and progenitor cells. The intracellular concentration of cyclic adenosine monophosphate (cAMP) in CD34(+) cells was diminished significantly upon stimulation of either CRH or orexin receptors, indicating that those are functionally active and coupled to inhibitory G proteins in human hematopoietic cells. In conclusion, these findings suggest a molecular interrelation of neuronal and hematopoietic signaling mechanisms in humans.


Subject(s)
Antigens, CD34/metabolism , Hematopoietic Stem Cells/cytology , Hematopoietic Stem Cells/metabolism , Receptors, Neurotransmitter/biosynthesis , Cell Adhesion , Cell Movement , Cytoskeletal Proteins/biosynthesis , Cytoskeleton/genetics , Cytoskeleton/metabolism , Dystroglycans , Extracellular Space/metabolism , Gene Expression Profiling , Hematopoietic Stem Cells/immunology , Hematopoietic Stem Cells/physiology , Humans , Intracellular Space/metabolism , Ion Channels/biosynthesis , Ion Channels/genetics , Membrane Glycoproteins/biosynthesis , Membrane Proteins/biosynthesis , Nerve Growth Factors/biosynthesis , Oligonucleotide Array Sequence Analysis , R-SNARE Proteins , RNA, Messenger/biosynthesis , Receptors, Neurotransmitter/genetics
13.
Brain Res ; 964(1): 159-63, 2003 Feb 21.
Article in English | MEDLINE | ID: mdl-12573525

ABSTRACT

Nitric oxide (NO) is a retrograde messenger involved in the processes of learning and memory. The role of the endothelial isoform of nitric oxide synthase (eNOS) in striatal synaptic plasticity was investigated in eNOS-deficient (eNOS(-/-)) and wild type (WT) mice. Tetanic stimulation of cortical afferents in WT mice evoked either long-term potentiation (LTP), or long-term depression (LTD) of cortico-striatal transmission. Both these plasticity related phenomena were NMDA-receptor-dependent; LTD was blocked by sulpiride, a dopamine D2-receptor antagonist. LTP occurrence in slices from eNOS(-/-) mice was significantly reduced when compared with WT mice. The NOS inhibitor NL-ARG reduced the occurrence of LTP and increased the occurrence of LTD in WT mice, resembling the balance of LTP/LTD in eNOS(-/-) mice. Impairment of NO-synthesis thus shifts striatal plasticity towards LTD. This indicates a possible involvement of eNOS from endothelia in neuronal modulation.


Subject(s)
Cerebral Cortex/enzymology , Neostriatum/enzymology , Neuronal Plasticity/physiology , Nitric Oxide Synthase/deficiency , Nitric Oxide/biosynthesis , Synapses/enzymology , Animals , Cerebral Cortex/cytology , Cerebral Cortex/growth & development , Dopamine Antagonists/pharmacology , Dopamine D2 Receptor Antagonists , Electric Stimulation , Enzyme Inhibitors/pharmacology , Excitatory Amino Acid Antagonists/pharmacology , Female , Learning/physiology , Long-Term Potentiation/drug effects , Long-Term Potentiation/physiology , Long-Term Synaptic Depression/drug effects , Long-Term Synaptic Depression/physiology , Male , Memory/physiology , Mice , Mice, Inbred C57BL , Mice, Knockout , Neostriatum/cytology , Neostriatum/growth & development , Nitric Oxide Synthase/antagonists & inhibitors , Nitric Oxide Synthase/genetics , Receptors, Dopamine D2/metabolism , Receptors, N-Methyl-D-Aspartate/drug effects , Receptors, N-Methyl-D-Aspartate/metabolism
14.
Drug News Perspect ; 16(10): 669-81, 2003 Dec.
Article in English | MEDLINE | ID: mdl-14747847

ABSTRACT

Orexins (hypocretins) are bioactive peptides linking arousal, appetite and neuroendocrine-autonomic control. Dysfunction of the orexin system is associated with narcolepsy-cataplexy. Here, we review drugs interfering with orexins directly such as novel selective orexin receptor agonists and antagonists, as well as drugs interfering with orexins indirectly such as those used for the treatment of narcolepsy-cataplexy, and pharmacological targets within the complex network of endogenous neurohumoral signals integrated and relayed by the orexin system. These include amines, acetylcholine, purines, GABA and glutamate, as well as nutritional-metabolic, circadian-photic, immunological and neuroendocrine-peptidergic influences. Basic and clinical evaluation of drugs interfering with the orexin system will lead to a better understanding of the molecular prerequisites that control behavioral state, stress responses, energy homeo- stasis and survival, and yield therapeutic advances for the treatment of narcolepsy and other disorders of sleep, eating, mood and memory.


Subject(s)
Carrier Proteins/metabolism , Central Nervous System Stimulants/pharmacology , Intracellular Signaling Peptides and Proteins , Neuropeptides/metabolism , Animals , Cataplexy/drug therapy , Cataplexy/pathology , Circadian Rhythm/drug effects , Circadian Rhythm/physiology , Humans , Narcolepsy/drug therapy , Narcolepsy/pathology , Neurotransmitter Agents/physiology , Orexin Receptors , Orexins , Receptors, G-Protein-Coupled , Receptors, Neuropeptide/agonists , Receptors, Neuropeptide/antagonists & inhibitors , Receptors, Neuropeptide/physiology
SELECTION OF CITATIONS
SEARCH DETAIL
...